Gene expression platforms
Search documents
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
Globenewswire· 2026-03-11 20:10
Core Viewpoint - Dyadic International, Inc. will report its financial results for the year ended December 31, 2025, and host a corporate update conference call on March 25, 2026 [1] Group 1: Financial Reporting - The financial results for the year ended December 31, 2025, will be announced on March 25, 2026 [1] - A corporate update conference call is scheduled for 5:00 p.m. Eastern Time on the same date [2] Group 2: Conference Call Details - Dial-in numbers for the conference call include a toll-free option: +1-877-407-9219 and +1 412-652-1274 [2] - The conference ID for the call is 13758915 [2] - A webcast link for the conference call is provided, and an archive will be available within 24 hours after the event [2] Group 3: Company Overview - Dyadic Applied BioSolutions is a global biotechnology company focused on producing recombinant proteins for life sciences, food and nutrition, and bio-industrial markets [4] - The company utilizes proprietary microbial platforms, specifically the C1 and Dapibus™ expression systems, to enable efficient and sustainable product development [4] - Dyadic's business model includes selling or licensing high-quality proteins to partners, supporting a growing portfolio of commercial and partnered programs [4]
Dyadic to Present at Investor Conferences and BPI East
Globenewswire· 2025-09-04 13:00
Core Insights - Dyadic International, Inc. is a global biotechnology company focused on scalable production of high-value, precision-engineered functional input proteins for non-therapeutic applications in life sciences, food and nutrition, and industrial biotechnology [1][2] Company Overview - Dyadic utilizes proprietary microbial platforms to produce recombinant proteins, which are sold or licensed to partners across various markets [2] - The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing, forming the foundation of a growing portfolio of commercial and partnered programs [2] Upcoming Events - Joe Hazelton, President & COO of Dyadic, will present at several upcoming conferences, including: - H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025 [1] - BioProcess International BPI East from September 15-18, 2025 [1] - Sidoti Small Cap Investor Event from September 17-18, 2025 [1] - The management team is open to connecting with investors, analysts, and industry partners during these events [1]